CJ, L., & YY, T. (2016). Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity. Dove Medical Press.
Chicago Style (17th ed.) CitationCJ, Lin, and Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.
MLA (8th ed.) CitationCJ, Lin, and Tsai YY. Axial Length, Refraction, and Retinal Vascularization 1 Year After Ranibizumab or Bevacizumab Treatment for Retinopathy of Prematurity. Dove Medical Press, 2016.
Warning: These citations may not always be 100% accurate.